All filters
Abstracts
High seroprevalence of viral hepatitis among animal handlers in Abeokuta, Nigeria
A. Oluremi Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Sustainability of immune response to hepatitis B virus vaccination three years after vaccination among HIV-1 infected and uninfected adults in Kenya
R. Kamoni Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Achieving sustained viral response (SVR) – is it a motivator for longterm positive lifestyle changes among people affected by VHC?
A. Schweitzer Reviews in Antiviral Therapy & Infectious Diseases 11, 2020  
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Co-located treatment verus co-located care coordination to engage people who inject drugs in HCV care at a syringe service program: preliminary results from the accessible care randomized clinical trial
B. Eckhardt Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Simplified HCV treatment model in primary healthcare in the country of Georgia
E. Dolmazashvili  Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Depist’c pharma an innovative outreach HCV screening project in pharmacy for drugs users and general population
A. Remy Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Videos
Challenges to Widespread PrEP in Europe: Social Aspects - Michael Meulbroek
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Challenges to Widespread PrEP in Europe: Clinical Aspects - Milosz Parczewski, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Overview of the current situation regarding PrEP and resistance - Daniel Kuritzkes, MD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
ViiV Pipeline - Michael Aboud, MBChB
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
HIV Pipeline - Kirsten White, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Hepatitis C Resistance: Pro Standpoint - Francesca Ceccherini - Silberstein, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Hepatitis C Resistance: Con Standpoint - JM Pawlotsky, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Treatment of Hepatitis B for HIV Clinicians - Anna Maria Geretti, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Management of the COVID 19 Pandemic in Europe: Diagnostics - Ravindra Gupta, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Resistance to Long-Acting Antivirals - Anne-Geneviève Marcelin, PharmD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Clinical Case - Romain Palich, MD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Implementing First Day Treatment in Europe: Western Perspective Margaret Johnson, MD, FRCP
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
First Day Treatment, Definition, and Review of Data Paul Sax, MD
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Transmitted and Acquired Resistance: Special Populations - Anca Streinu - Cercel, MD, PhD
Presented at:
European Meeting on HIV & Hepatitis 2020